(NYSE: CLVT) today announced that, to further enhance the Company’s governance profile, it has decreased the size of its Board of Directors from 14 to 11 members. Three directors, Balakrishnan S. Iyer, Kosty Gilis and Roxane White, have voluntarily agreed to resign, effective immediately.
Following these changes to the Board, 10 of its 11 directors are independent and 5 of its members, or 45%, are female or racially diverse.
Andrew Snyder, Chair of the Clarivate Board, said, “Our decision to reduce the size of the Board reflects our commitment to operating consistent with best practices in corporate governance. We believe having a smaller Board will improve efficiency and decision-making as we focus on driving long-term profitable growth and enhancing value for shareholders. Our continuing directors bring diverse and deep experience in technology, information services, corporate finance, M&A and human resources.”
Mr. Snyder added, “We thank Bala, Kosty and Roxane for their service and many contributions to the Company. They have been valued leaders and advisors as the Company entered the public markets and completed large acquisitions that tripled Clarivate’s size and transformed the Company into a global leader in data, information and workflow solutions.”
Clarivate’s continuing Board members include Mr. Snyder, Valeria Alberola, Michael J. Angelakis, Usama N. Cortas, Adam T. Levyn, Anthony Munk, Jane Okun Bomba, Dr. Wendell Pritchett, Richard W. Roedel and Sheryl von Blucher, along with Jonathan Gear, Clarivate’s Chief Executive Officer.
Clarivate™ is a global leader in providing solutions to accelerate the pace of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of Academia & Government, Life Sciences & Healthcare, Professional Services and Consumer Goods, Manufacturing & Technology. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.